NCT05896943View on ClinicalTrials.gov

The Application of Transcriptomics in the Treatment of Ulcerative Colitis With Ustekinumab

CompletedOBSERVATIONAL

Enrollment

38

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

October 31, 2023

Study Completion Date

September 25, 2024

Conditions

Ulcerative Colitis

Interventions

DRUG

Ustekinumab

Patients with ulcerative colitis treated with ustekinumab

Trial Locations (1)

10676

Evangelismos Hospital, Athens

All Listed Sponsors

lead

Evangelismos Hospital

OTHER